Source: Inflammation. Unidade: FMRP
Subjects: QUIMIOCINAS, COMORBIDADE, DIABETES MELLITUS INSULINO-DEPENDENTE, MACRÓFAGOS, MYCOBACTERIUM TUBERCULOSIS, OBESIDADE
ABNT
CORRÊA, Giseli Furlan et al. Chemerin exacerbates pulmonary inflammation in type 2 diabetes and mycobacterium tuberculosis infection comorbidity. Inflammation, 2025Tradução . . Acesso em: 14 abr. 2026.APA
Corrêa, G. F., Martins, N. S., Cipriano, U. G., Gembre, A. F., Rodrigues, D., Apolloni, V. B., et al. (2025). Chemerin exacerbates pulmonary inflammation in type 2 diabetes and mycobacterium tuberculosis infection comorbidity. Inflammation. doi:10.1007/s10753-025-02343-zNLM
Corrêa GF, Martins NS, Cipriano UG, Gembre AF, Rodrigues D, Apolloni VB, Ramalho LNZ, Fraga-Silva TF de C, Passaglia R de CAT, Bonato VLD. Chemerin exacerbates pulmonary inflammation in type 2 diabetes and mycobacterium tuberculosis infection comorbidity. Inflammation. 2025 ;[citado 2026 abr. 14 ]Vancouver
Corrêa GF, Martins NS, Cipriano UG, Gembre AF, Rodrigues D, Apolloni VB, Ramalho LNZ, Fraga-Silva TF de C, Passaglia R de CAT, Bonato VLD. Chemerin exacerbates pulmonary inflammation in type 2 diabetes and mycobacterium tuberculosis infection comorbidity. Inflammation. 2025 ;[citado 2026 abr. 14 ]
